Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark H Greene

Showing results (41-50 of 219) with videos related to

Pageof 22
Sort By:
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|September 23, 2014
Effects of false-positive cancer screenings and cancer worry on risk-reducing surgery among BRCA1/2 carriersDavid B Portnoy, Jennifer T Loud, Paul K J Han, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 13, 2015
Prospectively Identified Incident Testicular Cancer Risk in a Familial Testicular Cancer CohortAnand Pathak, Charleen D Adams, Jennifer T Loud, et al.
Hereditary Cancer in Clinical Practice|June 2, 2009
Factors associated with testicular self-examination among unaffected men from multiple-case testicular cancer familiesSusan T Vadaparampil, Richard P Moser, Jennifer Loud, et al.
BMC Complementary and Alternative Medicine|May 2, 2008
Complementary and alternative medicine use among women at increased genetic risk of breast and ovarian cancerChristine M Mueller, Phuong L Mai, Jaime Bucher, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 19, 2007
Constitutional cytogenetic analysis in men with hereditary testicular germ cell tumor: no evidence of disease-related abnormalitiesChristine M Mueller, Larissa Korde, Hormuzd A Katki, et al.
Cancer Causes & Control : CCC|July 31, 2009
Hypothesis: neoplasms in myotonic dystrophyChristine M Mueller, James E Hilbert, William Martens, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|September 26, 2008
BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experienceAlexis D Bakos, Sadie P Hutson, Jennifer T Loud, et al.
Cancer Medicine|April 18, 2015
Nontesticular cancers in relatives of testicular germ cell tumor (TGCT) patients from multiple-case TGCT familiesMary L McMaster, Ketil R Heimdal, Jennifer T Loud, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 30, 2019
A Pragmatic Testing-Eligibility Framework for Population Mutation Screening: The Example of <i>BRCA1/2</i>Ana F Best, Margaret A Tucker, Megan N Frone, et al.
Muscle & Nerve|July 21, 2018
Cancer phenotype in myotonic dystrophy patients: Results from a meta-analysisJose I Emparanza, Adolfo López de Munain, Mark H Greene, et al.
Pageof 22

Showing results (41-50 of 219) with videos related to

Sort By:
Pageof 22
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|September 23, 2014
Effects of false-positive cancer screenings and cancer worry on risk-reducing surgery among BRCA1/2 carriersDavid B Portnoy, Jennifer T Loud, Paul K J Han, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 13, 2015
Prospectively Identified Incident Testicular Cancer Risk in a Familial Testicular Cancer CohortAnand Pathak, Charleen D Adams, Jennifer T Loud, et al.
Hereditary Cancer in Clinical Practice|June 2, 2009
Factors associated with testicular self-examination among unaffected men from multiple-case testicular cancer familiesSusan T Vadaparampil, Richard P Moser, Jennifer Loud, et al.
BMC Complementary and Alternative Medicine|May 2, 2008
Complementary and alternative medicine use among women at increased genetic risk of breast and ovarian cancerChristine M Mueller, Phuong L Mai, Jaime Bucher, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 19, 2007
Constitutional cytogenetic analysis in men with hereditary testicular germ cell tumor: no evidence of disease-related abnormalitiesChristine M Mueller, Larissa Korde, Hormuzd A Katki, et al.
Cancer Causes & Control : CCC|July 31, 2009
Hypothesis: neoplasms in myotonic dystrophyChristine M Mueller, James E Hilbert, William Martens, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|September 26, 2008
BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experienceAlexis D Bakos, Sadie P Hutson, Jennifer T Loud, et al.
Cancer Medicine|April 18, 2015
Nontesticular cancers in relatives of testicular germ cell tumor (TGCT) patients from multiple-case TGCT familiesMary L McMaster, Ketil R Heimdal, Jennifer T Loud, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 30, 2019
A Pragmatic Testing-Eligibility Framework for Population Mutation Screening: The Example of <i>BRCA1/2</i>Ana F Best, Margaret A Tucker, Megan N Frone, et al.
Muscle & Nerve|July 21, 2018
Cancer phenotype in myotonic dystrophy patients: Results from a meta-analysisJose I Emparanza, Adolfo López de Munain, Mark H Greene, et al.
Pageof 22